BMS-833923

BMS-833923
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T2299-5mg 5 mg

7 - 10 business days*

44.00€
TGM-T2299-1mL 1 ml

7 - 10 business days*

51.00€
TGM-T2299-10mg 10 mg

7 - 10 business days*

70.00€
TGM-T2299-25mg 25 mg

7 - 10 business days*

122.00€
TGM-T2299-50mg 50 mg

7 - 10 business days*

196.00€
TGM-T2299-100mg 100 mg

7 - 10 business days*

355.00€
TGM-T2299-200mg 200 mg

7 - 10 business days*

522.00€
TGM-T2299-500mg 500 mg

7 - 10 business days*

831.00€
 
Description: BMS-833923 (XL-139), an orally bioavailable Smoothened antagonist, inhibits BODIPY... more
Product information "BMS-833923"
Description: BMS-833923 (XL-139), an orally bioavailable Smoothened antagonist, inhibits BODIPY cyclopamine binding to SMO in a dose-dependent manner (IC50: 21 nM). Target: Apoptosis, Smo, Hedgehog/Smoothened. Smiles: CNCc1ccc(C)c(NC(=O)c2ccc(Nc3nc(-c4ccccc4)c4ccccc4n3)cc2)c1. References: Tang JY, et al. Semin Cutan Med Surg. 2011, 30(4 Suppl), S14-18.
Keywords: XL-139
Supplier: TargetMol
Supplier-Nr: T2299

Properties

MW: 473.57 D
Formula: C30H27N5O

Database Information

CAS : 1059734-66-5| Matching products

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "BMS-833923"
Write a review
or to review a product.
Viewed